These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6391505)

  • 41. [The biology of Paragonimus westermani ichunensis in the Maritime Territory. Experimental research].
    Besprozvannykh VV
    Med Parazitol (Mosk); 1994; (4):28-31. PubMed ID: 7715551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of ELISA for the diagnosis of paragonimiasis westermani.
    Imai J
    Trans R Soc Trop Med Hyg; 1987; 81(1):3-6. PubMed ID: 3127958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action.
    Andrews P
    Arzneimittelforschung; 1981; 31(3a):538-41. PubMed ID: 7016122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent progress in studies of paragonimus and paragonimiasis control in China.
    Zhong HL; He LY; Xu ZB; Cao WJ
    Chin Med J (Engl); 1981 Aug; 94(8):483-94. PubMed ID: 6791889
    [No Abstract]   [Full Text] [Related]  

  • 45. [Early clinical symptoms and signs of paragonimiasis westermani, time course when intradermal test with Paragonimus westermani antigen turns positive and effects of praziquantel on paragonimiasis].
    Kanzaki T; Tanaka M; Nozaki T; Kanazawa T; Kobayashi M; Yokogawa M; Yoshida S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Mar; 23(3):368-73. PubMed ID: 4032878
    [No Abstract]   [Full Text] [Related]  

  • 46. Paragonimiasis and its intermediate hosts in a transmission focus in Lao People's Democratic Republic.
    Odermatt P; Habe S; Manichanh S; Tran DS; Duong V; Zhang W; Phommathet K; Nakamura S; Barennes H; Strobel M; Dreyfuss G
    Acta Trop; 2007 Aug; 103(2):108-15. PubMed ID: 17626777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persisting antibody reaction in paragonimiasis after praziquantel treatment is elicited mainly by egg antigens.
    Cho SY; Kong Y; Yun DH; Kang SY; Kim LS; Chung YB; Yang HJ
    Korean J Parasitol; 2000 Jun; 38(2):75-84. PubMed ID: 10905068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of bithionol against Paragonimus ohirai and Paragonimus miyazakii in diffusion chambers implanted intraperitoneally or subcutaneously in rats.
    Hashiguchi Y; Hirai H; Okura T; Hiraoka H
    J Parasitol; 1976 Feb; 62(1):146-7. PubMed ID: 1255365
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical experience with praziquantel in the treatment of Nigerian patients infected with S. haematobium.
    Oyediran AB; Kofie BA; Bammeke AO; Bamgboye EA
    Arzneimittelforschung; 1981; 31(3a):581-4. PubMed ID: 7016124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paragonimus westermani: life cycle, intermediate hosts, transmission to man and geographical distribution in Korea.
    Kim DC
    Arzneimittelforschung; 1984; 34(9B):1180-3. PubMed ID: 6542389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunoelectrophoresis For Anthelmintics Evaluation Against Experimental Paragonimiasis].
    Choi WY; Kimura K; Tsuji M
    Kisaengchunghak Chapchi; 1976 Dec; 14(2):94-102. PubMed ID: 12913437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical types and bitin treatment of paragonimiasis of the central nervous system--an analysis of 24 cases].
    Yang QD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Feb; 16(1):1-4. PubMed ID: 6872696
    [No Abstract]   [Full Text] [Related]  

  • 53. A new record of Paragonimus other than P. westermani in southern Thailand.
    Rangsiruji A; Sugiyama H; Morishima Y; Kameoka Y; Donsakul T; Binchai S; Ketudat P
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():57-61. PubMed ID: 17547054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Active hepatic capsulitis caused by Paragonimus westermani infection.
    Sasaki M; Kamiyama T; Yano T; Nakamura-Uchiyama F; Nawa Y
    Intern Med; 2002 Aug; 41(8):661-3. PubMed ID: 12211538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular discrimination between individual metacercariae of Paragonimus heterotremus and P. westermani occurring in Thailand.
    Sugiyama H; Morishima Y; Rangsiruji A; Binchai S; Ketudat P; Kameoka Y; Kawanaka M
    Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():102-6. PubMed ID: 16438190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paragonimus heterotremus infection in Nagaland: A new focus of Paragonimiasis in India.
    Singh TS; Sugiyama H; Umehara A; Hiese S; Khalo K
    Indian J Med Microbiol; 2009; 27(2):123-7. PubMed ID: 19384034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Epidemiological study of Paragonimus sp. in south Cameroon].
    Ollivier G; Boussinesq M; Albaret JL; Cumberlidge N; Farhati K; Chippaux JP; Bayssade-Dufour C
    Bull Soc Pathol Exot; 1995 Mar; 88(4):164-9. PubMed ID: 8640078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pulmonary paragonimiasis in a Gabonese child (author's transl)].
    Deméocq F; Déchelotte P; Pétavy AF; Cambon M
    Arch Fr Pediatr; 1980 Mar; 37(3):191-2. PubMed ID: 7469699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further studies on the effect of cyclosporin A on the course of Paragonimus infection in rats.
    Hashiguchi Y; Okamura Y
    J Helminthol; 1989 Dec; 63(4):328-32. PubMed ID: 2600414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.